# Dr Caplan&#8217;s Research Assistant: Direct Access to Clinical Cannabis Intelligence &amp; 128,000+ Curated Studies

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/ask/
> **Published:** 2026-09-12T13:48:04-04:00 | **Last Modified / Clinically Audited:** 2026-10-29T16:13:43-04:00
> **Clinical Summary:** This Cannabis Research Assistant teaches about cannabis, dosing, and interactions. Powered by clinical insights from 400,000 patients and 74,000+ curated studies.

---

[Research Assistant
 128,110
 
 Clinical AI Intelligence Platform · Dr. Benjamin Caplan, MD](https://cedclinic.com)

 
 
 [Book Visit ➔](https://cedclinic.com/book/)
 
 

 
 
 
 
 
 
 
 
 
 

# Dr. Caplan’s Research Assistant

 
 Clinical Intelligence · 400,000 Patients · 128,110+ Studies
 
 

 Suggested Clinical Explorations:
 
 
 
 

 
 

 
 
 
 
 
 
 
 The Research Assistant is an evidence-grounded scientific intelligence tool. Educational & non-prescriptive: consult your clinical team for personalized care.
 
 

 
 
 

 
 
 
 

## Inside the Clinical Intelligence Architecture

 

Explore the proprietary research frameworks, translational radars, and observational cohort analytics powering Dr. Caplan’s knowledge engine.

 
 
 
 

 
 
 
 
 
 
 
 
 
 Comprehensive Clinical Evidence & Study Corpus Summary
 Slide 1 of 10
 
 

 
 
 
 
 
 
 Real-World Evidence (RWE) & Longitudinal Cohort Footprint
 Slide 2 of 10
 
 

 
 
 
 
 
 
 CMRA Translational Discordance Radar & Opioid Reduction
 Slide 3 of 10
 
 

 
 
 
 
 
 
 Top 20 Therapeutic Target Domains & Cannabinoid Heatmap
 Slide 4 of 10
 
 

 
 
 
 
 
 
 POEMs: Patient-Oriented Evidence vs. Preclinical Inferences
 Slide 5 of 10
 
 

 
 
 
 
 
 
 Cross-Study Inferential Meta-Analysis & Entourage Synthesis
 Slide 6 of 10
 
 

 
 
 
 
 
 
 Literature White-Space & Unexamined Clinical Research Gaps
 Slide 7 of 10
 
 

 
 
 
 
 
 
 Receptor Binding Affinity Profiles & Target Dynamics
 Slide 8 of 10
 
 

 
 
 
 
 
 
 Human Clinical Trial Outcomes & Observational Registries
 Slide 9 of 10
 
 

 
 
 
 
 
 
 Longitudinal Care Plans & Diagnostic Scope Breakdown
 Slide 10 of 10
 
 

 

 
 
 
 
 
 
 🔒
 For private access to Dr. Caplan’s Cannabis Literature Intelligence System:
 
 
 Institutional licensing, researcher API access, and clinician collaborative intelligence.
 
 
 
 
 
 
 

 
 

 

 
 
 
 
 
 

 
 
 
 
 

## Why the Research Assistant Delivers Unmatched Evidence Provenance

 

Navigating cannabinoid science requires distinguishing rigorous clinical trial data from widespread marketing claims. **The Research Assistant** provides clinicians, researchers, and patients with instant access to an authoritative knowledge base rooted in peer-reviewed biomedical literature and decades of front-line clinical experience.

 
 Physician-Built Full-Stack Architecture
 

### Not a Generic Chatbot: Grounded Clinical RAG with Zero Hallucination Guardrails

 

Unlike commercial AI wrappers that summarize generic web chatter, **The Research Assistant** was custom-engineered from the ground up by Dr. Benjamin Caplan, MD. Operating as a full-stack clinician-developer, Dr. Caplan designed a proprietary Retrieval-Augmented Generation (RAG) architecture connecting exclusively to the **CED Command Center**—a curated observatory of 128,000+ peer-reviewed studies.

 
 Direct Primary Source Attribution
 Algorithmic Retraction Monitoring
 Client-Privacy Preserving
 
 

 
 **400,000 Patient Encounters**
 

Real-world clinical observations providing deep insight into cannabinoid tolerance, efficacy, and side-effect management across diverse patient populations.

 
 
 **128,110+ Curated Studies**
 

Systematic indexing of randomized controlled trials (RCTs), biochemical assays, receptor binding profiles, and pharmacokinetic analyses.

 
 
 **Evolutionary Care Integration**
 

Continuous medical updates reflecting the latest discoveries in endocannabinoid system (ECS) pharmacology and targeted therapeutics.

 
 

 

## Explore Cannabinoid Mechanisms, Dosing, and CYP450 Interactions

 

Cannabinoids interact with multiple physiological systems beyond classic CB1 and CB2 receptors, including TRPV1 vanilloid channels, 5-HT1A serotonin receptors, and PPAR-gamma nuclear receptors. Understanding these diverse pathways is essential for anticipating biphasic dose responses and identifying potential metabolic interactions involving the cytochrome P450 enzyme family (CYP3A4, CYP2C9, CYP2C19).

 

## Frequently Asked Questions About the Research Assistant

 
 
 
 How was the Research Assistant built and who developed it?
 
 

The Research Assistant was architected and coded de novo by board-certified Family Medicine physician and full-stack software engineer Dr. Benjamin Caplan, MD. Rather than using an off-the-shelf third-party chatbot wrapper, Dr. Caplan engineered a proprietary retrieval-augmented generation (RAG) pipeline directly connected to the CED Command Center’s database of 128,000+ peer-reviewed papers. Every query is constrained by strict clinical guardrails designed by a physician to prevent AI hallucination and cite verifiable primary literature.

 
 

 
 What is the Research Assistant?
 
 

The Research Assistant is a specialized clinical AI intelligence platform curated by board-certified physician Dr. Benjamin Caplan, MD. It synthesizes insights from over 400,000 patient encounters and 128,110+ peer-reviewed scientific publications to deliver instant, evidence-grounded answers to medical cannabis questions.

 
 

 
 Is the Research Assistant providing direct medical prescriptions?
 
 

No. The Research Assistant is an evidence-grounded scientific and educational tool designed to demystify cannabinoid pharmacology, clinical trial data, and therapeutic research. It is non-prescriptive and intended to inform discussions between patients and their licensed healthcare providers.

 
 

 
 How does the Research Assistant handle drug interactions and safety?
 
 

The platform cross-references known cytochrome P450 (CYP3A4, CYP2C9, CYP2C19) enzymatic pathways, evaluating pharmacokinetic interactions between major cannabinoids (such as THC, CBD, CBG, and CBN) and standard pharmaceutical medications like blood thinners, antiepileptics, and sedatives.

 
 

 
 Where do the scientific citations come from?
 
 

Every clinical summary references peer-reviewed biomedical literature indexed on PubMed, NCBI, and international clinical trial registries, complete with direct DOI and PMID links for full verification.

 
 

 
 How can healthcare providers use the Research Assistant in clinical workflows?
 
 

Clinicians use the engine to quickly review biphasic dose-response curves, examine specific cannabinoid receptor affinities (CB1, CB2, TRPV1, 5-HT1A), and access recent human randomized controlled trial data to support evidence-based patient consultations.

 
 

 
 How can I schedule a direct consultation with Dr. Benjamin Caplan?
 
 

Patients and healthcare professionals seeking individualized clinical evaluations can book directly through CED Clinic at [cedclinic.com/book](https://cedclinic.com/book/) for comprehensive medical guidance.

 
 
 

 
 
 

### Looking for Personalized Medical Cannabis Guidance?

 

Schedule a one-on-one telehealth consultation with Dr. Benjamin Caplan for customized clinical care plans.

 [Book Clinical Consultation ➔](https://cedclinic.com/book/)

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
